Gil Morgan, MD(@weoncologists) 's Twitter Profileg
Gil Morgan, MD

@weoncologists

Clinical Oncologist from Texas🇺🇸Director of @OncoAlert 🚨 Proudly NIH, NCI & MDA trained. An ounce of prevention equals a pound of cure. Views are own🌏

ID:39742016

calendar_today13-05-2009 12:44:05

19,6K Tweets

16,5K Followers

7,6K Following

Follow People
ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo

➡️ Enhance your ESMO membership! Register now to delve into knowledge and engage with experts in real-time. Don't miss out on staying informed and connected. Register now: 🔗 ow.ly/Ix9C50ROHpk

➡️ Enhance your ESMO membership! Register now to delve into #BreastCancer knowledge and engage with experts in real-time. Don't miss out on staying informed and connected. Register now: 🔗 ow.ly/Ix9C50ROHpk
account_circle
Nadia Harbeck,MD PhD(@Prof_Nadia_H) 's Twitter Profile Photo

Very good and balanced discussion by Dr. Krop today. Hopefully we will get the approval extension soon so that we can individualize treatment with TDXd in HER2-low MBC like he suggested in his algorithm OncoAlert

account_circle
Dra. María Natalia Gandur Quiroga(@nataliagandur) 's Twitter Profile Photo

💫🌟Thank you ONCOassist® | The go-to oncology app !!
💖It was a pleasure to work with such a fantastic team. 🌍🌏🌎
I am grateful for the opportunity to collaborate with Emre Yekedüz, Gil Morgan, MD, from OncoAlert Martin Krasnapolski , and Matthew Izzo, MPP from the National Comprehensive Cancer Network (NCCN).
🔥👩‍🎓👨‍🎓🔝Looking forward to more

account_circle
Icro Meattini(@Icro_Meattini) 's Twitter Profile Photo

European Society of Radiotherapy and Oncology (ESTRO) ESTRO strategy 2024–2026: Growth and diversification in a rapidly changing world


Radiotherapy & Oncology OncoAlert thegreenjournal.com/article/S0167-…

account_circle
Icro Meattini(@Icro_Meattini) 's Twitter Profile Photo

Essential requirements for reporting radiation therapy in clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)
ESTRO OncoAlert


thegreenjournal.com/article/S0167-…

account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

Dear Colleagues at ,
Our friends/partners at @mirrorsmedwould like to invite all to and in Vienna🇦🇹 this November To See How GU Data is Translated into Clinical Practice

REGISTER HERE: prosca-bladdr.org/global-forum-o…

Petros Grivas

Dear Colleagues at #ASCO24, Our friends/partners at @mirrorsmedwould like to invite all to #PROSCA24 #BLADDR24 and #RENALC24 in Vienna🇦🇹 this November To See How GU Data is Translated into Clinical Practice REGISTER HERE: prosca-bladdr.org/global-forum-o… @PGrivasMDPhD
account_circle
Erika Hamilton, MD(@ErikaHamilton9) 's Twitter Profile Photo

Dr. Krop highlights 2 🔑 points:

💢TDXd should be used AFTER endocrine therapies

🤔 If we have ~90% that are clearly HER-2 expressing, should we even test? Especially knowing that previous data shows w/ serial biopsy we can always find a HER-2 low.



OncoAlert

Dr. Krop highlights 2 🔑 points: 💢TDXd should be used AFTER endocrine therapies 🤔 If we have ~90% that are clearly HER-2 expressing, should we even test? Especially knowing that previous data shows w/ serial biopsy we can always find a HER-2 low. #ASCO24 #bcsm @OncoAlert
account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

Dear Colleagues,
During 🇺🇸we are Highlighting the Next Generation of Colleagues. We proudly introduce Coral Olazagasti, MD who talks to us about the Going Back home Study.

Best,
The Network

'Going Back Home study was created to understand the journeys of migration of

account_circle
Al-Ola A Abdallah MD (USMIRC)(@Abdallah81MD) 's Twitter Profile Photo

The comparison of two manuscripts NEJM showcasing Belantamab's superiority over other anti-myeloma treatments in a head-to-head comparison is widely considered the greatest comeback in the history of myeloma.
FDA Oncology USMIRC News OncoAlert

The comparison of two manuscripts @NEJM showcasing Belantamab's superiority over other anti-myeloma treatments in a head-to-head comparison is widely considered the greatest comeback in the history of myeloma. @FDAOncology #mmsm #myeloma #medtwitter #USMIRC @USMIRCNEWS @OncoAlert
account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

Dear Colleagues at
OncoAlert 🚨and COSMO

Have come together to bring you these videos by
Eleonora Teplinsky, MD Martina Murphy, MD and Gil Morgan, MD
on Following Social Media for the BEST experience.

We Continue with Dr. Teplinsky Discussing 'Steps to Curate the BEST

account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

Dear Colleagues at
A warm invitation from our OncoAlert 🚨faculty Maryam Lustberg MD MPH from Yale Cancer Center to attend TODAY:
4:30PM at Arie Crown Theater

The Dr. Bernard Fisher Memorial Annual Clinical Science Symposium: Emerging Role of ctDNA in

account_circle